These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 25391902)

  • 1. The role of adenosine A1 and A2A receptors in the caffeine effect on MDMA-induced DA and 5-HT release in the mouse striatum.
    Górska AM; Gołembiowska K
    Neurotox Res; 2015 Apr; 27(3):229-45. PubMed ID: 25391902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for adenosine A(1) receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine release.
    Vanattou-Saïfoudine N; Gossen A; Harkin A;
    Eur J Pharmacol; 2011 Jan; 650(1):220-8. PubMed ID: 20951694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.
    Górska AM; Kamińska K; Wawrzczak-Bargieła A; Costa G; Morelli M; Przewłocki R; Kreiner G; Gołembiowska K
    Neurotox Res; 2018 Apr; 33(3):532-548. PubMed ID: 29134560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats.
    Vanattou-Saïfoudine N; McNamara R; Harkin A
    Br J Pharmacol; 2010 Jun; 160(4):860-77. PubMed ID: 20590585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDMA induced dopamine release in vivo: role of endogenous serotonin.
    Koch S; Galloway MP
    J Neural Transm (Vienna); 1997; 104(2-3):135-46. PubMed ID: 9203077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate.
    Nixdorf WL; Burrows KB; Gudelsky GA; Yamamoto BK
    J Neurochem; 2001 Apr; 77(2):647-54. PubMed ID: 11299327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
    Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A; Salem A; Irvine RJ
    Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.
    Bankson MG; Cunningham KA
    J Pharmacol Exp Ther; 2001 Jun; 297(3):846-52. PubMed ID: 11356903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat.
    Koprich JB; Campbell NG; Lipton JW
    Brain Res Dev Brain Res; 2003 Dec; 147(1-2):177-82. PubMed ID: 14741762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release.
    Bankson MG; Yamamoto BK
    J Neurochem; 2004 Nov; 91(4):852-9. PubMed ID: 15525339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').
    Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
    Neuropsychopharmacology; 2005 Mar; 30(3):550-60. PubMed ID: 15496938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic interactions between MDMA and concomitants in MDMA tablets on extracellular dopamine and serotonin in the rat brain.
    Ikeda R; Igari Y; Fuchigami Y; Wada M; Kuroda N; Nakashima K
    Eur J Pharmacol; 2011 Jun; 660(2-3):318-25. PubMed ID: 21497593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain.
    Riegert C; Wedekind F; Hamida SB; Rutz S; Rothmaier AK; Jones BC; Cassel JC; Jackisch R
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):743-63. PubMed ID: 18248690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
    Nash JF; Brodkin J
    J Pharmacol Exp Ther; 1991 Nov; 259(2):820-5. PubMed ID: 1682486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of "Legal X" piperazine analogs on dopamine and serotonin release in rat brain.
    Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB
    Ann N Y Acad Sci; 2004 Oct; 1025():189-97. PubMed ID: 15542717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase C inhibition differentially affects 3,4-methylenedioxymethamphetamine-induced dopamine release in the striatum and prefrontal cortex of the rat.
    Nair SG; Gudelsky GA
    Brain Res; 2004 Jul; 1013(2):168-73. PubMed ID: 15193525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT(1B) receptor.
    Amato JL; Bankson MG; Yamamoto BK
    Neuropsychopharmacology; 2007 Apr; 32(4):946-54. PubMed ID: 16885935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition potential of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites on the in vitro monoamine oxidase (MAO)-catalyzed deamination of the neurotransmitters serotonin and dopamine.
    Steuer AE; Boxler MI; Stock L; Kraemer T
    Toxicol Lett; 2016 Jan; 243():48-55. PubMed ID: 26721607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.